← Leaderboards
Michael. Ian Phillips
University Of Florida
$4,978,596
Attributed
$4,978,596
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $369.8K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$4,978,596 · 7
By mechanism
R01$2,015,072 · 2
R37$1,369,546 · 1
G20$638,293 · 1
P50$489,442 · 1
T35$266,243 · 1
S07$200,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Mohan K. Raizada$21,242,274
- Colin Sumners$12,690,977
- Carl J Pepine$14,456,715
- Qiuhong Li$3,933,810
- Michael Aron Lane$3,021,942
Others in their field
Top investigators on “Antisense Nucleic Acid”
- Jeffrey S Glenn · Stanford University$8,915,196
- Ke Zhang · Northeastern University$7,536,805
- Luciano A Marraffini · Rockefeller University$5,932,500
- Charles A Thornton · Virginia Commonwealth University$5,654,221
- David R. Corey · University Of Texas Sw Med Ctr/Dallas$5,651,763
- Michael G Rosenfeld · University Of California, San Diego$5,595,046
Research focus
Antisense Nucleic AcidTransfection /Expression VectorRenal HypertensionMessenger RnaLaboratory MouseDisease /Disorder ModelOligonucleotidesAngiotensin /Renin /Aldosterone HypertensionSpontaneous Hypertensive RatTransfectionReceptor BindingAntihypertensive AgentsElectrolyte BalanceActive SitesAngiotensin IiHormone ReceptorAngiotensin ReceptorLaboratory RatGene TherapyGenetically Modified AnimalsHeart FailureNonhuman Therapy EvaluationDrug Screening /EvaluationEnzyme Activity
Grant awards (21)
Regulated gene and stem cell induced cardioprotection$359,123
R01 · FY2007 · HL · contact PI
Regulated gene and stem cell induced cardioprotection$369,849
R01 · FY2006 · HL · contact PI
Regulated gene and stem cell induced cardioprotection$362,500
R01 · FY2005 · HL
UNIVERSITY OF SOUTH FLORIDA MOUSE BARRIER FACILITY$638,293
G20 · FY2004 · RR
Regulated gene and stem cell induced cardioprotection$362,500
R01 · FY2004 · HL
CENTRAL ANGIOTENSIN IN FLUID BALANCE &HYPERTENSION$209,602
R37 · FY2004 · HL
CENTRAL ANGIOTENSIN IN FLUID BALANCE &HYPERTENSION$65,295
R37 · FY2004 · HL
CENTRAL ANGIOTENSIN IN FLUID BALANCE &HYPERTENSION$267,070
R37 · FY2003 · HL
Beta1 Adrenoreceptor Antisense Control in Heart Failure$246,269
R01 · FY2003 · HL
Enhancing Subject Protections through Education$100,000
S07 · FY2003 · RR
Beta1 Adrenoreceptor Antisense Control in Heart Failure$24,831
R01 · FY2003 · HL
Beta1 Adrenoreceptor Antisense Control in Heart Failure$290,000
R01 · FY2002 · HL
CENTRAL ANGIOTENSIN IN FLUID BALANCE &HYPERTENSION$258,398
R37 · FY2002 · HL
SHORT-TERM RESEARCH TRAINING FOR MINORITY STUDENTS$102,692
T35 · FY2002 · HL
Adverse Events: Quantative Risk Assessment Tool$100,000
S07 · FY2002 · RR
CENTRAL ANGIOTENSIN IN FLUID BALANCE &HYPERTENSION$250,869
R37 · FY2001 · HL
VIRAL VECTOR DELIVERY OF ANTISENSE TO ACE MRNA IN CARDIOVASCULAR DISEASE$219,976
P50 · FY2001 · HL
SHORT-TERM RESEARCH TRAINING FOR MINORITY STUDENTS$74,208
T35 · FY2001 · HL
CENTRAL ANGIOTENSIN IN FLUID BALANCE &HYPERTENSION$318,312
R37 · FY2000 · HL
VIRAL VECTOR DELIVERY OF ANTISENSE TO ACE MRNA IN CARDIOVASCULAR DISEASE$269,466
P50 · FY2000 · HL
SHORT-TERM RESEARCH TRAINING FOR MINORITY STUDENTS$89,343
T35 · FY2000 · HL